OncoGenex Pharmaceuticals Inc is a biopharmaceutical company committed to the development and commercialization of new cancer therapies that address treatment resistance in cancer patients.


Updates from The Motley Fool

Latest updates on OncoGenex Pharmaceuticals from Fool.com.
A Dendreon Killer? Not Yet.

Johnson & Johnson's abiraterone looks good, but won't knock off the newcomer.



Stock Performance

View Interactive OGXI Charts
Sponsored by

Key Data Points

Primary metrics and data points about OncoGenex Pharmaceuticals.
Current Price: $0.36
Prev Close: $0.36
Open: $0.35
Bid: $0.34
Ask: $0.40
Day's Range: $0.34 - $0.36
52wk Range: $0.33 - $1.32
Volume: 182,398
Avg Vol 152,889
Market Cap: $11M
P/E (ttm): -0.55
EPS (ttm): ($0.66)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about OncoGenex Pharmaceuticals.
CAPS Rating 2 out of 5
 
92 Outperform
37 Underperform
CAPS All Stars
 
12 Outperform
12 Underperform

How do you think OncoGenex Pharmaceuticals will perform against the market?



You pick for OncoGenex Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Scott Cormack, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for OncoGenex Pharmaceuticals.

OncoGenex Pharmaceuticals Inc is a biopharmaceutical company committed to the development and commercialization of new cancer therapies that address treatment resistance in cancer patients.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers